As a common vascular abnormality in the central nervous system, cerebral cavernous malformations (CCMs) require the upregulation of the phosphatidylinositol-3-kinase-mTOR pathway and the loss of CCM complex function to grow. The gene discussed is MTOR; the disease is famililal cerebral cavernous malformations.